EVALUATE THE CONCENTRATION OF SERUM CFDNA AND INTEGRITY AS A NON-INVASIVE MARKER TO DISTINGUISH BETWEEN MALIGNANT AND BENIGN BREAST LESION. Romanian Journal of Diabetes, Nutrition and Metabolic Diseases, [S. l.], v. 31, n. 1, p. 366–389, 2024. Disponível em: https://jrdiabet.ro/index.php/RJDNMD/article/view/304.. Acesso em: 18 may. 2024.